LD 1580 Would Hike Health Care Costs for more than 716,000 Maine Families, Employers, and Unions

Legislative Document 1580 is a Big Pharma-driven proposal targeting pay-for-performance incentives in the private health care market that would increase health care costs for Maine patients, unions and employers.

Instead of lowering the cost of prescription drugs, this bill will undermine market-based savings, drive up insurance premiums and increase out-of-pocket costs for over 716,000 Maine residents who rely on employer or union-provided health coverage.

Employers and unions negotiate better deals on prescription drugs by hiring pharmacy benefit managers (PBMs), critical members of the health care system that pool their negotiating power to unlock savings for health plan sponsors, and the patients and families on these plans.

LD 1580 would ban pay-for-performance incentives in the private health care marketplace that are essential for Maine employers and unions to secure significant savings on prescription drugs. Banning these incentives will lead directly to higher premium costs for Maine’s patients.

This bill is not about protecting patients—it’s about lining Big Pharma’s pockets.

Maine residents can’t afford a bill that increases health care costs while doing nothing to lower prescription drug prices. Contact your legislators today and tell them to reject LD 1580.